10 Results for "

9-PAHSA

" in MedChemExpress (MCE) Product Catalog:
Products (10)

10 Results for "9-PAHSA" in MCE Product Catalog:

9-PAHSA
9-PAHSA
0 Images
Cat. No.: HY-120657
CAS No.: 1481636-31-0
Purity:  99.88%
Category:  

Ketones, Aldehydes, Acids Other Diseases Endogenous metabolite Disease Research Fields

Target:  

CGRP Receptor NF-κB

9-PAHSA is an orally active endogenous GPR120 agonist (EC50=18 μM). 9-PAHSA significantly inhibits LPS-induced inflammatory responses by blocking the NF-κB pathway. 9-PAHSA induces adipocyte browning, enhances glucose uptake and reduces lipid accumulation, while improving mitochondrial function and the survival rate of steatotic hepatocytes. In terms of neuroprotection, 9-PAHSA regulates the expression of REST and BDNF in the prefrontal cortex of diabetic mice, and effectively prevents spatial working memory deficits and abnormal social behaviors. 9-PAHSA does not directly regulate insulin secretion or improve systemic insulin sensitivity, and possesses specific anti-inflammatory, metabolic regulatory and neuroprotective properties. 9-PAHSA can be used in the research of diabetes-related cognitive impairment, obesity and non-alcoholic fatty liver disease .
loading...
    loading...
View All Sizes
9-PAHSA (Standard)
9-PAHSA (Standard)
0 Images
Cat. No.: HY-120657R
CAS No.: 1481636-31-0
Category:  

Ketones, Aldehydes, Acids Endogenous metabolite

Target:  

Reference Standards CGRP Receptor NF-κB

Flumethrin (Standard) is the analytical standard of Flumethrin. This product is intended for research and analytical applications. 9-PAHSA is an orally active endogenous GPR120 agonist (EC50=18 μM). 9-PAHSA significantly inhibits LPS-induced inflammatory responses by blocking the NF-κB pathway. 9-PAHSA induces adipocyte browning, enhances glucose uptake and reduces lipid accumulation, while improving mitochondrial function and the survival rate of steatotic hepatocytes. In terms of neuroprotection, 9-PAHSA regulates the expression of REST and BDNF in the prefrontal cortex of diabetic mice, and effectively prevents spatial working memory deficits and abnormal social behaviors. 9-PAHSA does not directly regulate insulin secretion or improve systemic insulin sensitivity, and possesses specific anti-inflammatory, metabolic regulatory and neuroprotective properties. 9-PAHSA can be used in the research of diabetes-related cognitive impairment, obesity and non-alcoholic fatty liver disease .
loading...
    loading...
View All Sizes
9-PAHSA-13C4
9-PAHSA-13C4
0 Images
Cat. No.: HY-W770410
CAS No.: 2748638-71-1
9-PAHSA- 13C4 is 13C-labeled 9-PAHSA. 9-PAHSAis an orally active endogenous GPR120 agonist (EC50=18 μM). 9-PAHSAsignificantly inhibits LPS-induced inflammatory responses by blocking the NF-κB pathway. 9-PAHSAinduces adipocyte browning, enhances glucose uptake and reduces lipid accumulation, while improving mitochondrial function and the survival rate of steatotic hepatocytes. In terms of neuroprotection, 9-PAHSAregulates the expression of REST and BDNF in the prefrontal cortex of diabetic mice, and effectively prevents spatial working memory deficits and abnormal social behaviors. 9-PAHSAdoes not directly regulate insulin secretion or improve systemic insulin sensitivity, and possesses specific anti-inflammatory, metabolic regulatory and neuroprotective properties. 9-PAHSAcan be used in the research of diabetes-related cognitive impairment, obesity and non-alcoholic fatty liver disease .
loading...
    loading...
View All Sizes
9-PAHSA-d4
9-PAHSA-d4
0 Images
Cat. No.: HY-120657S
CAS No.: 2704278-85-1
9-PAHSA-d4 is the deuterium labeled 9-PAHSA. 9-PAHSA is an orally active endogenous GPR120 agonist (EC50=18 μM). 9-PAHSA significantly inhibits LPS-induced inflammatory responses by blocking the NF-κB pathway. 9-PAHSA induces adipocyte browning, enhances glucose uptake and reduces lipid accumulation, while improving mitochondrial function and the survival rate of steatotic hepatocytes. In terms of neuroprotection, 9-PAHSA regulates the expression of REST and BDNF in the prefrontal cortex of diabetic mice, and effectively prevents spatial working memory deficits and abnormal social behaviors. 9-PAHSA does not directly regulate insulin secretion or improve systemic insulin sensitivity, and possesses specific anti-inflammatory, metabolic regulatory and neuroprotective properties. 9-PAHSA can be used in the research of diabetes-related cognitive impairment, obesity and non-alcoholic fatty liver disease .
loading...
    loading...
View All Sizes
9-PAHSA-d9
9-PAHSA-d9
0 Images
Cat. No.: HY-144026S
CAS No.: 1809222-43-2
9-PAHSA-d9 is the deuterium labeled 9-PAHSA (HY-120657). 9-PAHSA is an orally active endogenous GPR120 agonist (EC50=18 μM). 9-PAHSA significantly inhibits LPS-induced inflammatory responses by blocking the NF-κB pathway. 9-PAHSA induces adipocyte browning, enhances glucose uptake and reduces lipid accumulation, while improving mitochondrial function and the survival rate of steatotic hepatocytes. In terms of neuroprotection, 9-PAHSA regulates the expression of REST and BDNF in the prefrontal cortex of diabetic mice, and effectively prevents spatial working memory deficits and abnormal social behaviors. 9-PAHSA does not directly regulate insulin secretion or improve systemic insulin sensitivity, and possesses specific anti-inflammatory, metabolic regulatory and neuroprotective properties. 9-PAHSA can be used in the research of diabetes-related cognitive impairment, obesity and non-alcoholic fatty liver disease .
loading...
    loading...
View All Sizes
9-PAHSA-d31
9-PAHSA-d31
0 Images
Cat. No.: HY-120657S1
CAS No.: 2748208-06-0
9-PAHSA-d31 is the deuterium labeled 9-PAHSA. 9-PAHSA is an orally active endogenous GPR120 agonist (EC50=18 μM). 9-PAHSA significantly inhibits LPS-induced inflammatory responses by blocking the NF-κB pathway. 9-PAHSA induces adipocyte browning, enhances glucose uptake and reduces lipid accumulation, while improving mitochondrial function and the survival rate of steatotic hepatocytes. In terms of neuroprotection, 9-PAHSA regulates the expression of REST and BDNF in the prefrontal cortex of diabetic mice, and effectively prevents spatial working memory deficits and abnormal social behaviors. 9-PAHSA does not directly regulate insulin secretion or improve systemic insulin sensitivity, and possesses specific anti-inflammatory, metabolic regulatory and neuroprotective properties. 9-PAHSA can be used in the research of diabetes-related cognitive impairment, obesity and non-alcoholic fatty liver disease .
loading...
    loading...
View All Sizes
1-Palmitoyl-2-9-pahsa-3-oleoyl-sn-glycerol
1-Palmitoyl-2-9-pahsa-3-oleoyl-sn-glycerol
0 Images
Cat. No.: HY-173547
Synonyms: TG(16:0/9-PAHSA/18:1)
Target:  

Endogenous Metabolite

Research Areas:  

Metabolic Disease

1-Palmitoyl-2-9-pahsa-3-oleoyl-sn-glycerol is a PAHSA-containing compound. 1-Palmitoyl-2-9-pahsa-3-oleoyl-sn-glycerol can be used in the research of adipose tissue .
loading...
    loading...
View All Sizes
9(R)-PAHSA
9(R)-PAHSA
0 Images
Cat. No.: HY-124281
CAS No.: 2097130-84-0
Target:  

NF-κB Akt Autophagy PI3K

Research Areas:  

Others

9(R)-PAHSA is a R-enantiomer of 9-PAHSA. 9-PAHSA is an orally available anti-inflammatory lipid that lowers blood sugar and reduces inflammation .
loading...
    loading...
View All Sizes
9(S)-PAHSA
9(S)-PAHSA
0 Images
Cat. No.: HY-124281A
CAS No.: 2097130-87-3
Target:  

Drug Isomer NF-κB

Research Areas:  

Others

9(S)-PAHSA is a S-enantiomer of 9-PAHSA. 9-PAHSA is an orally available anti-inflammatory lipid that lowers blood sugar and reduces inflammation .
loading...
    loading...
View All Sizes
5-PAHSA-d9
5-PAHSA-d9
0 Images
Cat. No.: HY-144024S
CAS No.: 1809226-17-2
5-PAHSA-d9 is the deuterium labeled 5-PAHSA (HY-116193). 5-PAHSA is a kind of anti-inflammatory and antidiabetic lipokines that connect glucose and lipid metabolism .
loading...
    loading...
View All Sizes
Assay Types